Chard Daniel R's Form 4 filing
Medifast Inc (MED) · filed Apr 21, 2022
- Accession no.
- 0001104659-22-048540
- Filed
- Apr 21, 2022
- Trade date
- Feb 4-Mar 21, 2022
- Filing delay
- 76 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $128.7K. It was filed 76 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chard Daniel RCIK 0001289557 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2022 | Common Stock | PPurchaseAcquired | +690.27 | $186.40 | +$128,666.33 | 103,839.27 | Indirect | |
| Feb 23, 2022 | Common Stock | GGiftDisposed | −3,375 | $0.00 | $0 | 16,886 | Direct | |
| Feb 23, 2022 | Common Stock | GGiftAcquired | +3,375 | $0.00 | $0 | 107,214.27 | Indirect | |
| Mar 21, 2022 | Common Stock | GGiftDisposed | −953 | $0.00 | $0 | 15,933 | Direct | |
| Mar 21, 2022 | Common Stock | GGiftAcquired | +953 | $0.00 | $0 | 108,167.27 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.